Concepedia

MARIE HISAMOTO

MH

Statistics

Publications

4

Citations

138

H-Index

4

Active since

1992

Affiliations

Biomedical Research Laboratories (United States)(Current)

Daiichi-Sankyo (Japan)

Daiichi Sankyo (Germany)

MARIE HISAMOTO is an author at Biomedical Research Laboratories (United States) specializing in neuroprotection, medicine, and neurochemistry.

Top concepts

MedicineApoptosisNeurologyCell DeathNeurosciencePharmacologyNeurochemistryNeurophysiologyNeuroprotectionSocial Sciences

Publications per year

1992–2002

4

Publications

4

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

Shigeko Uryu, Jun Harada, MARIE HISAMOTO et al. · Brain Research · 2002 · 76 citations

Neurophysiology, Post-glutamate Neurotoxicity, Medicine +12

Folipastatin, a new depsidone compound from Aspergillus unguis as an inhibitor of phospholipase A2. Taxonomy, fermentation, isolation, structure determination and biological properties.

KIYOSHI HAMANO, M Kinoshita-Okami, ATSUKO HEMMI et al. · The Journal of Antibiotics · 1992 · 29 citations · Full text

N-Type Calcium Channel Blockers from a Marine Bacterium, Cytophaga sp. SANK 71996.

Tadaaki Morishita, Aiya Sato, MARIE HISAMOTO et al. · The Journal of Antibiotics · 1997 · 19 citations · Full text

A-53930A and B, Novel N-Type Ca2+ Channel Blockers.

MARIE HISAMOTO, YOSHINORI INAOKA, YOSHIHARU SAKAIDA et al. · The Journal of Antibiotics · 1998 · 14 citations · Full text

1–4 of 4